SmartPill Aims To Address Quality-Of-Life GI Disorders With SmartPill Capsule
This article was originally published in The Gray Sheet
Executive Summary
SmartPill Diagnostics, Inc. will conduct a 100-patient, five-center clinical trial to support a 510(k) application for its SmartPill Capsule ingestible diagnostic for gastrointestinal disorders
You may also be interested in...
Given Imaging Recruits J&J To Help Drive GERD Capsule Procedure Referrals
Johnson & Johnson's Ethicon Endo-Surgery unit will market Given Imaging's M2A Esophageal Capsule to gastro-esophageal reflux disorder (GERD) patients and their primary care physicians under an exclusive sales and co-marketing deal
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.